
Alexion Pharmaceuticals Investor Relations Material
Latest events

Q4 2020
8 Feb, 2021

Q4 2019
4 Feb, 2020
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Alexion Pharmaceuticals Inc
Access all reports
Alexion Pharmaceuticals Inc focused on the development and commercialization of therapies for rare diseases. The company specialized in biologics targeting immune-mediated rare conditions and offered treatments across neurology, hematology, nephrology, and metabolic disorders. Alexion operated globally through research, manufacturing, and commercial networks. The company was headquartered in Boston, Massachusetts, and its shares were listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
ALXN
Country
🇺🇸 United States